The European Commission has published a report delineating the scene for paediatric medicines after five years from the entry into force of EU Paediatric Regulation (Reg.1901/2006/EC). The document entitled 'Better medicines for children – from concept to reality'...
The Proposal for an European Regulation on clinical trials, repealing the CT Directive 2001/20/EC, has received the first reading approval last May 29th by the ENVI EP Committee. Many advancements are expected by the new Regulation, including the creation of a public...
The European Commission has approved the project “Clonidine for sedation of paediatric patients in the paediatric intensive care unit” (CloSed) in the framework of FP7. CloSed is coordinated by the University Hospital of Erlangen (Germany) and involves other partners...
Fondazione Gianni Benzi is pleased to inform you that the National Centre for Rare Diseases in collaboration with the Italian National Institute of Health have organized for the second year the International Summer School “Clinical practice guidelines on rare...
Fondazione Gianni Benzi has launched its new e-learning course entitled 'Marketing a drug for human use in Europe'. The Course deals with the procedures to be followed in order to obtain a Marketing Authorisation according to European rules, with particular focus on:...
In the General Hospital of Bari’s Federico Vecchio hall, in collaboration with the “Hereditary anemias in the child” CIR of the “F. Vecchio” Pediatric Operating Unit of Bari’s General Hospital, the Gianni Benzi Pharmacological Research Foundation introduced to the...
In January 2013 the book-document of Prof. Annagrazia Altavilla entitled “The Research on the Stem Cells” (La Recherche sur les Cellules Souches, Harmattan Editor) was published. It is only available in French. Professor Jean-François Mattei, ex Minister of Health in...
In February 2013, Alessandro Donati presented his new book entitled “Lo Sport del Doping” (300 pages, €16,00, Edizioni Gruppo Abele) in the framework of a national tour. There are many doping scandals involving top athletes and it is largely known that doping is a...
In the framework of the project "Towards Personalized Medicine: Development of new selective molecules for the treatment of Neuroblastoma", a call for selection has been issued for 2 graduates to be employed with a fixed-term contract (36 months), in the framework of...
On the 21st of August 2012, an article by a research group lead by Prof. Cavalletti, a member of the Foundation’s Scientific Committee, was published on the prestigious journal "Annals of Oncology” of the Oxford University Press. The article “The chemotherapy-induced...
Recent posts in News